AR015036A1 - Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento - Google Patents
Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamentoInfo
- Publication number
- AR015036A1 AR015036A1 ARP990101975A ARP990101975A AR015036A1 AR 015036 A1 AR015036 A1 AR 015036A1 AR P990101975 A ARP990101975 A AR P990101975A AR P990101975 A ARP990101975 A AR P990101975A AR 015036 A1 AR015036 A1 AR 015036A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- alkoxy
- manufacture
- phenyl
- Prior art date
Links
- -1 INDOLYL Chemical class 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 abstract 1
- 101150065749 Churc1 gene Proteins 0.000 abstract 1
- 102100038239 Protein Churchill Human genes 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical group C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- QNLOWBMKUIXCOW-UHFFFAOYSA-N indol-2-one Chemical compound C1=CC=CC2=NC(=O)C=C21 QNLOWBMKUIXCOW-UHFFFAOYSA-N 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- FGFUBBNNYLNVLJ-UHFFFAOYSA-N indolone Natural products C1=CC=C2C(=O)C=NC2=C1 FGFUBBNNYLNVLJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Derivados de indolilo antisicotico de la formula general (1) en donde: R1 y R2 son cada uno independientemente seleccionados entre H, OH, F, Cl, Br, I,alquilo C1-6 o alquenilo C1-6, alcoxi C1-6, arilo, OR5, nitro, amino, CF3, fenilo, bencilo, benciloxi o piridina, los anillos aromáticos de los cuales sonoptativamente sustituidos por entre 1 a 3 sustituyentes seleccionados entre halogeno, alquilo C1-6, alcoxi C1-6, S-alquilo C1-6, -CN, -OH, -NO2 o CF3; o R1 yR2 son tomados conjuntamente, forman un anillo fusionado en las posiciones 1,2 o 2,3 proporcionando un grupo fenilo fusionado o un grupo benzodioxano, o ungrupo indol 4- o 7-sustituido, o un grupo quinolina 4- o 5- u 8-sustituido; R3 representa un grupo seleccionado entre hidrogeno, alquilo C1-6, alcoxi C1-4 o unhalogeno; R4 representa un grupo seleccionado entre hidrogeno, alquilo C1-6 o R5; R5 es CH2Ph en el cual el anillo fenilo puede estar optativamente sustituidopor un grupo seleccionado entre OMe, halogeno, CF3; X se selecciona entre un grupo representado por N, CR4, CHR4 y CHCH; A se selecciona entre un gruporepresentado por N, NH, CH y CH2; B se selecciona entre un grupo representado por =O, =S, H y H2; o A y B pueden estar concatenados juntos para formarporciones indol, benzimidazol, indolona o indolina; o su sal farmacéuticamente aceptable; composiciones farmacéuticas para el tratamiento de los trastornos delsistema nervioso central utilizando estos compuestos y su uso para la manufactura de un medicamento.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6912998A | 1998-04-29 | 1998-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015036A1 true AR015036A1 (es) | 2001-04-11 |
Family
ID=22086935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101975A AR015036A1 (es) | 1998-04-29 | 1999-04-28 | Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1076647A2 (es) |
| JP (1) | JP2002513001A (es) |
| CN (1) | CN1155567C (es) |
| AR (1) | AR015036A1 (es) |
| AU (1) | AU3667899A (es) |
| CA (1) | CA2330452A1 (es) |
| WO (1) | WO1999055672A2 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA004704B1 (ru) * | 1999-05-24 | 2004-06-24 | Мицубиси Фарма Корпорейшн | Производные феноксипропиламина |
| AU1057401A (en) * | 1999-11-11 | 2001-06-06 | Senju Pharmaceutical Co., Ltd. | Pancreatitis remedies |
| US6844344B2 (en) | 1999-12-20 | 2005-01-18 | Eli Lilly And Company | Benzofuran derivatives |
| AU1930901A (en) * | 1999-12-20 | 2001-07-03 | Eli Lilly And Company | Azabicyclo(3.2.1)octane derivatives |
| AR027134A1 (es) * | 1999-12-30 | 2003-03-12 | Lundbeck & Co As H | Derivados de indol. |
| US20040014788A1 (en) * | 2000-11-14 | 2004-01-22 | Gerd Bartoszyk | Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists |
| WO2002048105A2 (en) * | 2000-11-16 | 2002-06-20 | Wyeth | Aryloxy piperidinyl derivatives for the treatment of depression |
| JP4042566B2 (ja) * | 2000-11-27 | 2008-02-06 | 田辺三菱製薬株式会社 | ピペリジン化合物およびその医薬用途 |
| HUP0400834A2 (hu) * | 2001-06-29 | 2004-08-30 | H. Lundbeck A/S | Új indolszármazékok és ezeket tartalmazó gyógyszerkészítmények |
| PL208258B1 (pl) | 2001-07-26 | 2011-04-29 | Merck Patent Gmbh | Nowe zastosowanie 2-[5-(4-fluorofenylo) -3- pirydylometyloaminometylo] -chromanu oraz jego fizjologicznie tolerowanych soli |
| AR033485A1 (es) * | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| AU2005264996A1 (en) | 2004-06-17 | 2006-01-26 | Wyeth | Gonadotropin releasing hormone receptor antagonists |
| JP2008503470A (ja) | 2004-06-17 | 2008-02-07 | ワイス | ゴナドトロピン放出ホルモン受容体アンタゴニストの製造法 |
| CN101084225B (zh) | 2004-11-26 | 2011-03-02 | 詹森药业有限公司 | 具有改良的抗精神病和抗焦虑活性的异噁唑啉-吲哚衍生物 |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| WO2007006677A1 (en) | 2005-07-13 | 2007-01-18 | F. Hoffmann-La Roche Ag | Benzimidazole derivatives as 5-ht6,5-ht24 |
| MX2009004898A (es) | 2006-11-09 | 2009-05-19 | Hoffmann La Roche | Derivados de indol y de benzofurano-2-carboxamida. |
| KR101457339B1 (ko) | 2008-07-28 | 2014-11-03 | 지앙쑤 구오후아 인베스트먼트 컴퍼니 리미티드 | 아랄킬 치환된 피페리딘 또는 피페라진 유도체 및 정신분열증 치료를 위한 이의 용도 |
| CN101973925B (zh) * | 2010-10-15 | 2012-03-28 | 中国药科大学 | 具有抗炎活性的2-吲哚酮类化合物、其制备方法及医药用途 |
| PL395469A1 (pl) * | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Pochodne indoloamin do leczenia chorób osrodkowego ukladu nerwowego |
| CN102871978B (zh) * | 2012-10-19 | 2014-04-09 | 河北仁合益康药业有限公司 | 一种左舒必利片及其制备方法 |
| CN116554145B (zh) * | 2022-01-29 | 2025-06-03 | 江苏恩华药业股份有限公司 | 芳烷基-4-(1h)吲哚基哌嗪衍生物、其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4335126A (en) * | 1977-03-10 | 1982-06-15 | Degussa Aktiengesellschaft | 1-[3-(3,4,5-Trimethoxyphenoxy)-2-hydroxy-propyl]-4-aryl-piperazine-derivatives having pharmaceutical activity |
| FR2567884B1 (fr) * | 1984-07-19 | 1987-03-06 | Roussel Uclaf | Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant |
| US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1999
- 1999-04-28 WO PCT/US1999/009132 patent/WO1999055672A2/en not_active Ceased
- 1999-04-28 CA CA002330452A patent/CA2330452A1/en not_active Abandoned
- 1999-04-28 AU AU36678/99A patent/AU3667899A/en not_active Abandoned
- 1999-04-28 CN CNB998078220A patent/CN1155567C/zh not_active Expired - Fee Related
- 1999-04-28 JP JP2000545832A patent/JP2002513001A/ja active Pending
- 1999-04-28 AR ARP990101975A patent/AR015036A1/es unknown
- 1999-04-28 EP EP99918863A patent/EP1076647A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999055672A2 (en) | 1999-11-04 |
| EP1076647A2 (en) | 2001-02-21 |
| CA2330452A1 (en) | 1999-11-04 |
| CN1155567C (zh) | 2004-06-30 |
| AU3667899A (en) | 1999-11-16 |
| CN1307562A (zh) | 2001-08-08 |
| JP2002513001A (ja) | 2002-05-08 |
| WO1999055672A3 (en) | 2000-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR015036A1 (es) | Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento | |
| ES2065895T3 (es) | 2-aminobenzotiazoles sustituidos y derivados de los mismos utiles como agentes cerebrovasculares. | |
| UA50767C2 (uk) | Похідні індолу, що використовуються як антагоністи рецептора ендотеліну, спосіб їх одержання, фармацевтична композиція та спосіб лікування | |
| HUP0002830A2 (hu) | Indol- és 2,3-dihidroindol-származékok, előállításuk és gyógyászati alkalmazásuk | |
| EA199700156A1 (ru) | Производные индола как антагонисты рецептора 5-нт | |
| ES2128092T3 (es) | Derivados de anilina. | |
| NO884729L (no) | Fremgangsmaate for fremstilling av kinoxalinforbindelser. | |
| ATE92057T1 (de) | Indol-derivate. | |
| ES2122289T3 (es) | Derivados de 5-arilindol. | |
| NO895196L (no) | Fremgangsmaate for fremstilling av kinoxalinforbindelser. | |
| AR056613A1 (es) | Compuestos derivados de lapachona, su preparacion y metodos de uso de los mismos para el tratamiento o prevencion de trastornos proliferativos celulares y composiciones farmaceuticas que los contienen | |
| BR0311593A (pt) | Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc | |
| AR006619A1 (es) | Derivados de aminopiridina, composicion farmaceutica que los contien, metodo para elaborar un medicamento, intermediario quimico para la produccionde dichos compuestos y procedimiento para preparar los derivados de aminopiridina | |
| AR008291A1 (es) | Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento. | |
| ES2154605A1 (es) | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 | |
| KR100855385B1 (ko) | 트립타민 및 동족 화합물의 유도체, 및 이들을 함유하는약제학적 제제 | |
| AR031197A1 (es) | Procedimiento para la preparacion de derivados de 1,2,3,4,8,9,10,10a-octahidro-7bh-ciclopenta(b) diazepino(6,7,1-hi)indol | |
| PT902684E (pt) | Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos | |
| AR023111A1 (es) | Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden | |
| AR015037A1 (es) | Derivados de indolilo, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento | |
| ES2111492B1 (es) | Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central. | |
| DE69514533D1 (de) | Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten | |
| ES551992A0 (es) | Procedimiento para preparar derivados de pirazol 3,4-d-priridin-3-ona. | |
| AR018899A1 (es) | Un derivado de indol e indolina 4-, 5-, 6- y 7- sustituido, una composicion farmaceutica que los comprende y el uso del mismo para la manufactura de unmedicamento | |
| AR095674A2 (es) | INHIBIDORES PERIFÉRICAMENTE SELECTIVOS DE DOPAMINA-b-HIDROXILASA Y MÉTODO PARA SU PREPARACIÓN |